Avidity Biosciences, Inc (RNAM) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.05x

Avidity Biosciences, Inc (RNAM) has a Cash Flow Reinvestment Rate of 0.05x as of December 2023, reinvesting $863.00K (capex $863.00K ) from operating cash flow of $16.50 Million. See free cash flow generation of Avidity Biosciences, Inc to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

$863.00K
Capex + Investments

Operating Cash Flow

$16.50 Million
USD

Capital Expenditures

$863.00K
USD

Avidity Biosciences, Inc Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Avidity Biosciences, Inc across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Avidity Biosciences, Inc generate cash.

Annual Cash Flow Reinvestment Rate for Avidity Biosciences, Inc (2019–2019)

Year-by-year capital reinvestment analysis for Avidity Biosciences, Inc. See Avidity Biosciences, Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 0.09x $235.00K $2.49 Million $235.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow